0
Kineta, Inc. has reached its limit for free report views
Work for Kineta, Inc.? Upgrade Your Profile and unlock all your annual reports.
Kineta, Inc.
- 11-50 Employees
- Based in Seattle, Washington
Kineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy.
Kineta, Inc.
Most Recent Annual Report
Report Locked. Kineta, Inc. has reached its limit for free report views.
